Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.52 USD | -0.13% | -5.90% | +2.22% |
Apr. 15 | Exact Sciences Names Aaron Bloomer CFO | MT |
Apr. 11 | Baxter International Inc. Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S | CI |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.68B | Capitalization | 20.13B |
---|---|---|---|---|---|
Net income 2024 * | 747M | Net income 2025 * | 960M | EV / Sales 2024 * | 1.94 x |
Net Debt 2024 * | 9.15B | Net Debt 2025 * | 8.02B | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
21
x | P/E ratio 2025 * |
17.5
x | Employees | 60,000 |
Yield 2024 * |
2.92% | Yield 2025 * |
3.16% | Free-Float | 74.06% |
Latest transcript on Baxter International Inc.
1 day | -0.13% | ||
1 week | -5.90% | ||
Current month | -7.53% | ||
1 month | -5.02% | ||
3 months | +2.15% | ||
6 months | +24.12% | ||
Current year | +2.22% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 215 M€ | +12.15% | - | |
1.23% | 18 M€ | +2.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 39.52 | -0.13% | 2,800,139 |
24-04-16 | 39.57 | -1.17% | 2,658,887 |
24-04-15 | 40.04 | -0.72% | 3,062,144 |
24-04-12 | 40.33 | -4.25% | 4,126,975 |
24-04-11 | 42.12 | +0.29% | 3,060,574 |
Delayed Quote Nyse, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.22% | 20.15B | |
-4.01% | 105B | |
-4.77% | 66.74B | |
+7.87% | 52.63B | |
+16.18% | 47.48B | |
-0.20% | 39.68B | |
+7.17% | 27.78B | |
-1.23% | 26.27B | |
+3.80% | 26.11B | |
+10.58% | 25.38B |
- Stock Market
- Equities
- BAX Stock